Quarterly report pursuant to Section 13 or 15(d)

Segments (Tables)

v2.4.0.8
Segments (Tables)
6 Months Ended
Jun. 30, 2013
Segment Reporting [Abstract]  
Information regarding our geographic activities
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended June 30,
 
For the six months ended June 30,
(In thousands)
2013
 
2012
 
2013
 
2012
Product revenues:
 
 
 
 
 
 
 
Pharmaceuticals
$
18,618

 
$
9,917

 
$
34,145

 
$
18,556

Diagnostics

 

 

 

Corporate

 

 

 

 
$
18,618

 
$
9,917

 
$
34,145

 
$
18,556

Revenue from services and transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceuticals
$
1,300

 
$

 
$
13,800

 
$

Diagnostics
3,823

 
243

 
7,132

 
330

Corporate
80

 
51

 
120

 
102

 
$
5,203

 
$
294

 
$
21,052

 
$
432

Operating (loss) income:
 
 
 
 
 
 
 
Pharmaceuticals
$
(4,528
)
 
$
(1,955
)
 
$
3,955

 
$
(3,317
)
Diagnostics
(6,750
)
 
(4,356
)
 
(16,384
)
 
(9,025
)
Corporate
(5,762
)
 
(3,030
)
 
(10,787
)
 
(5,846
)
Less: Operating loss attributable to noncontrolling interests
(943
)
 

 
(1,540
)
 

 
$
(17,983
)
 
$
(9,341
)
 
$
(24,756
)
 
$
(18,188
)
Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceuticals
$
1,702

 
$
1,575

 
$
3,397

 
$
3,025

Diagnostics
1,704

 
835

 
3,393

 
1,669

Corporate
45

 
44

 
90

 
88

 
$
3,451

 
$
2,454

 
$
6,880

 
$
4,782

Revenues:
 
 
 
 
 
 
 
United States
$
5,203

 
$
294

 
$
21,052

 
$
432

Chile
8,482

 
7,187

 
16,223

 
12,888

Spain
5,153

 

 
9,477

 

Israel
3,995

 
1,518

 
6,567

 
3,145

Mexico
988

 
1,212

 
1,878

 
2,523

 
$
23,821

 
$
10,211

 
$
55,197

 
$
18,988

(In thousands)
June 30,
2013
 
December 31,
2012
Assets:
 
 
 
Pharmaceuticals
$
336,266

 
$
142,299

Diagnostics
114,095

 
112,422

Corporate
190,719

 
35,109

 
$
641,080

 
$
289,830

Goodwill:
 
 
 
Pharmaceuticals
$
34,480

 
$
32,844

Diagnostics
47,606

 
47,606

Corporate

 

 
$
82,086

 
$
80,450